Invert
YC W22San Francisco, US · Founded 2021 · Delaware corporation · 25 employees · Hiring · 5 known investors
Find your way into Invert
821 people in our graph share verified history with the Invert team — schools, employers, funds. One of them is your warm intro.
Linaunlockedknows Holger Thorup · together at Copenhagen Business School (overlapped)
×9knows the team · via Y Combinator
knows the team · via Copenhagen Business School
knows the team · via Airbnb
Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.
Also known as Invert Bio
AI & Machine LearningBiotechData & InfrastructureEnterprise SoftwareHealthtechCellular AgricultureMachine LearningSynthetic BiologyUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (W22)
Invert was founded in 2021 by Martin T. Permin and Holger Thorup.
MT
Martin T. Perminin𝕏Co-Founder/ceoMartin Permin previously worked at Airbnb and Hive (a Y Combinator-backed company). He has a background in biology and data.
HT
Holger Thorupin𝕏Co-Founder & CTOHolger Thorup was VP of Engineering at ZeroNorth and co-founder and CTO at Pelion. He has background in management consulting.
SC
Sam CatesNamed on SEC filing
Board
CT
Investors · 5
Reported raises · per SEC filings
Form D private placements$20.1M disclosed across 1 round · 2024
▶$20.1MraisedJul 2024 · 16 investors · Other TechnologyRule 506(b)
▶$20.1MraisedJul 2024 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Martin Tromp PerminExecutive Officer, Director
- Holger Hjorth ThorupDirector
- Christian Tang-JespersenDirector
- Sam CatesDirector
- Offering amount
- $21.7M
- Amount sold
- $20.1M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Invert went on to found or lead other companies.
Competitors · 5
by search overlap
Recursion (NASDAQ: RXRX)6 shared keywordsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
Surf5 shared keywordsSurf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector. The technology enables at-home subcutaneous self-injection of monoclonal antibodies and biologics as an alternative to in-clinic IV infusion, and is offered to pharmaceutical API manufacturers through partnerships.
Revvity4 shared keywordsRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Converge Bio4 shared keywordsConverge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies. The company provides AI solutions for target discovery, antibody design, protein manufacturing optimization, and biomarker discovery.
Inductive Bio4 shared keywordsInductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.
Companies competing with Invert for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Invert do?
- Invert provides infrastructure and intelligence software that connects bioprocess equipment and data sources for pharmaceutical and biologics companies, enabling faster process development and manufacturing through integrated data platforms and digital twin capabilities.
- Who founded Invert?
- Invert was founded by Martin T. Permin, Holger Thorup in 2021.
- Who are Invert's investors?
- Invert's investors include ACME Capital, Cathexis Ventures, Giant Ventures Global Llp, Y Combinator, TechNexus Venture Collaborative.
- How much funding has Invert raised?
- Invert has disclosed $20.1M raised across 1 round.
- Where is Invert headquartered?
- Invert is headquartered in San Francisco, US.